June 2020, Vol 174, No. 6, Pages 517-628
Affording Genetic Therapies in the Medicaid Program
Jeromie Ballreich, PhD, MHS; Ijeamaka Ezebilo, MD, MPH; Joshua Sharfstein, MD
JAMA Pediatr. 2020;174(6):523-524. doi:10.1001/jamapediatrics.2020.0168
This Viewpoint describes the costs of genetic therapies for children covered by Medicaid and suggests strategies to decrease these costs and thus increase access to these drugs.